Bayer Ag ADR (OP:BAYRY)

12.64 -0.09 (-0.71%)

Delayed Quote Updated: 3:59 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag ADR

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

22nd Century Group Reports Q1 Net Sales Of $9M, Up 33% YoY, Net Loss Also Grows ↗

May 05, 2022

22nd Century Group, Inc. (NASDAQ: XXII) reported results for the first quarter ended March 31, 2022.. The company will host a live audio webcast on May 5, at 10:00 a.m. ET.

Via Benzinga

Investment Strategy Monthly Insights, April 2022 ↗

April 22, 2022

After four decades of low inflation, developed economies are grappling with an inflation spike.

Via Talk Markets

FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs ↗

April 21, 2022

The FDA aims to put the PI3K inhibitor drug class under a more stringent regulatory scope as the inhibitor has demonstrated substantial toxicity.

Via Benzinga

Merck Projects $10 Billion From Its Next Blockbuster Segment; Will It Measure Up? ↗

April 05, 2022

Merck shares hit a six-month high Tuesday on the bullish projection.

Via Investor's Business Daily

What Stocks Do Well During a Bear Market? 7 Picks for a Downturn ↗

March 16, 2022

These are the best bear market stocks to invest in now. T, BG and CL are some great picks for investors looking to weather the storm.

Via InvestorPlace

Recap: Bayer Q4 Earnings ↗

March 01, 2022

Bayer (OTC:BAYRY) reported its Q4 earnings results on Tuesday, March 1, 2022 at 01:30 AM. Here's what investors need to know about the announcement. Earnings Bayer beat...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia ↗

March 15, 2022

Eli Lilly And Co (NYSE: LLY) said it would continue to supply drugs to Russia for urgent medical conditions such as cancer and diabetes but will suspend sales of "non-essential medicines."

Via Benzinga

The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial ↗

March 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy ↗

March 15, 2022

Exelixis Inc (NASDAQ: EXEL) announced results from the final analysis of the second primary endpoint of overall survival (OS) from the phase 3 COSMIC-312 trial of Cabometyx (cabozantinib) plus...

Via Benzinga

Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them? ↗

February 17, 2022

Can the formerly red-hot biotech segment return to its previous glory?

Via Investor's Business Daily

Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer ↗

February 15, 2022

Aveo Pharmaceuticals Inc (NASDAQ: AVEO) will present new long-term progression-free survival (PFS) data from the Phase 3 TIVO-3 study in kidney cancer at the 2022...

Via Benzinga

Why Are Evotec Shares Trading Lower On Friday? ↗

February 04, 2022

Bayer AG (OTC: BAYRY) has

Via Benzinga

The Journey To Rewrite Human DNA Is About To Get Wild, Thanks To Pfizer, Bayer, Intellia And Other CRISPR stocks ↗

January 13, 2022

Big Pharma is paying attention to CRISPR stocks. Could that alight shares this year?

Via Investor's Business Daily

Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer ↗

January 10, 2022

Pfizer and Bayer inked deals with several companies in gene-editing.

Via Investor's Business Daily

Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table ↗

December 23, 2021

This article was originally published on The Bluntness, and ...

Via Benzinga

Recursion, Bayer Expand Fibrosis Pact To Include Inferential Search Capabilities ↗

December 06, 2021

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) expanded its existing strategic collaboration in fibrosis with Bayer AG (OTC: BAYRY). The expanded...

Via Benzinga

Even Good Penny Stocks Like Senseonics Aren’t Always Profitable ↗

December 03, 2021

Its latest implanted sensor lasts six months, but SENS stock faces competition from Dexcom, Abbott Labs and potentially one big name in tech.

Via InvestorPlace

Bayer's Nubeqa Shows Prolonged Survival In Late-Stage Prostate Cancer Trial ↗

December 03, 2021

Bayer AG (OTC: BAYRY) said a combination therapy, including its Nubeqa drug, was shown to prolong the lives of men who have metastatic prostate cancer in a clinical...

Via Benzinga

Microsoft, Bayer Collaborate To Develop Digital Agricultural Tools, Capabilities ↗

November 17, 2021

Microsoft Corp (NASDAQ: MSFT) and Bayer AG (OTC: BAYRY) (OTC: BAYZF) collaborated on new internet-based products aimed at helping farmers and industries...

Via Benzinga

The Secret To Successful Investing In Biotech ↗

October 19, 2021

Have you ever had a stock jump 30%, 50% or 100% in one day?

Via Talk Markets

Agricultural Technology Companies Are Finding Themselves in a Global Race to Develop and Acquire New Intellectual Property ↗

October 18, 2021

Image by AgriFORCE The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga...

Via Benzinga

The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO ↗

October 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Adcom Recommends Approval Of Moderna's COVID-19 Vaccine Booster Shot For...

Via Benzinga

Here’s What Happens When You Beat The Market By 5% (And How To Do It) ↗

October 11, 2021

See, the way Wall Street makes money has fundamentally shifted in recent years. So has the way information flows to individual investors. And today I want to show you how savvy stock pickers can profit...

Via Talk Markets

I See Another “Chipotle Moment” ↗

September 27, 2021

Lawsuits are terrible for business. They bring distractions, extra costs, and uncertainty. Big Tobacco knows this all too well.

Via Talk Markets

Topics Lawsuit

Acceleron Stock Heats Up On $11 Billion Takeover Rumor; So, Who's The Buyer? ↗

September 27, 2021

A biotech working in lung and blood diseases, as well as cancer, could be acquired.

Via Investor's Business Daily

BWXT Medical, Bayer AG Ink Agreement On Actinium-225 ↗

September 16, 2021

BWX Technologies Inc's (NYSE: BWXT) subsidiary BWXT Medical Ltd. has agreed with Bayer AG (OTC: BAYRY) to develop Actinium-225 (Ac-225) supply and...

Via Benzinga

Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration ↗

August 24, 2021

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related...

Via Benzinga

Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates ↗

August 11, 2021

Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed...

Via Benzinga

Topics Earnings

3 Pharma Stocks to Buy in August ↗

August 11, 2021

These stocks offer solid growth opportunities.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.